However, in the non–high-risk patients, the difference did not reach statistical significance between the two groups.
← all excerpts
Different Patient Subgroup Different Maintenance, Proteasome Inhibitors or Immunomodulators Maintenance for Newly Diagnosed Multiple Myeloma: A 7-Year Single-Center Date in China.
1
—
—